Covid-19 virus via Columbia University
Since the first reports of a new coronavirus disease in Wuhan, China, in December 2019, COVID-19 has spread rapidly across the globe, threatening a pandemic. Now, researchers from CAS, a division of the American Chemical Society specializing in scientific information solutions, have issued a special report in ACS Central Science. In the report, they provide an overview of published scientific information on potential therapeutic agents and vaccines for the virus, with an emphasis on patents.
According to the World Health Organization, as of March 2, 2020, COVID-19 caused almost 90,000 confirmed illnesses and more than 3,000 deaths. The responsible virus, known as SARS-CoV-2, primarily attacks the lower respiratory system to cause viral pneumonia, but it may also affect the gastrointestinal system, heart, kidney, liver and central nervous system. If SARS-CoV-2 is not quickly contained, the virus could have devastating effects on people’s lives, worldwide health systems and the global economy. To assist with research efforts to discover therapies and vaccines for COVID-19, Cynthia Liu led a group of CAS scientists who analyzed the published scientific data on SARS-CoV-2 and related coronaviruses.
The researchers reviewed the rapidly growing body of journal articles related to COVID-19 and SARS-CoV-2, as well as patents having to do with human coronaviruses. From the last week of 2019 through March 1, 2020, more than 500 journal articles related to the virus were published electronically or in print, with numbers steadily increasing week-by-week. Topics included clinical manifestations, treatment regimens, viral structure and mechanisms, antiviral agents, and diagnostics. To date, more than 500 patents have been issued for vaccines and for therapeutic agents, such as antibodies, cytokines and nucleic acids, that could help prevent or treat coronavirus infections. Because SARS-CoV-2 is similar to other coronaviruses, such as SARS-CoV-1 and MERS-CoV, the researchers highlighted therapies previously explored for these other viruses that could also be applicable to SARS-CoV-2.
The authors do not acknowledge any funding sources for this study.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19
- 6 Cleveland area residents plead guilty to illegally obtaining nearly $3 million in COVID-19 unemployment assistance funds
Court documents alleged that the Northeast Ohioans illegally obtained nearly $3 million in Federal Pandemic Unemployment Assistance (PUA) benefits.
- Where is COVID-19 spreading? These states have the highest COVID rates
The United States is in the midst of a summer wave of COVID-19 fueled by highly contagious, new variants sweeping the country from coast to coast. As summer travel peaks, experts are warning people to take precautions to stop the spread, no matter the ...
Go deeper with Google Headlines on:
COVID-19
[google_news title=”” keyword=”COVID-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
COVID-19 vaccine
- Pfizer takes $230M hit after axing failed DMD gene therapy—and tosses out RSV combo vaccine
Pfizer’s phase 3 Duchenne muscular dystrophy (DMD) gene therapy failure has blown a $230 million hole in the New York pharma's second quarter ...
- Swiss pharmacies face Covid-19 vaccine shortages amid summer wave
Switzerland is facing a summer wave of Covid-19, with pharmacies and doctors’ surgeries struggling with vaccine shortages.
- AstraZeneca Withdraws Covid-19 Vaccine Citing Decline In Demand After Admitting To ‘Rare’ Side Effects
AstraZeneca has begun the process of withdrawing the Covid-19 vaccine worldwide citing a “surplus of available updated vaccines.” ...
- Creating the Next Generation of mRNA Vaccines
Harvard Medical School researchers at Boston Children’s Hospital have now developed two technologies that could make these and future mRNA vaccines more potent and longer-lasting — at smaller doses ...
- Navy to clear records for some sailors who refused COVID-19 vaccine
The Navy will clear records for sailors who refused the COVID-19 vaccine due to religious objections, according to a lawsuit settlement reached between the service and sailors last week. The ...
Go deeper with Google Headlines on:
COVID-19 vaccine
[google_news title=”” keyword=”COVID-19 vaccine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]